Companies: 10,795·Total market cap: $144.5T
Gritstone bio, Inc.

Gritstone bio, Inc.

GRTSNASDAQHealthcare
$0.03
$-0.02(-31.78%)
Market Cap$3803110
P/E Ratio
52W High$3.17
52W Low$0.03

Gritstone bio, Inc. (GRTS) Revenue

Annual & quarterly revenue history · segment & region breakdown

GRTS · revenue · updated Jun 9, 2026

Core revenue metrics

Gritstone bio, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
2.24×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$7K
231 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Gritstone bio, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
GRTS revenue by year · GRTS revenue history · GRTS annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Gritstone bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Gritstone bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Gritstone bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

GRTS revenue · 4 questions

GRTS's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

GRTS revenueGRTS annual revenuewhat is GRTS revenueGRTS TTM revenue

Source: FMP · Gritstone bio, Inc. SEC filings · GAAP · Gritstone bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026